Ask about this product for this use
For Medicare, the reason a medicine is prescribed can change whether it is eligible for coverage.
In September 2026, Medicare’s usual prescription drug benefit, Part D, continues to exclude medicines prescribed for weight loss.
Certain other uses, such as diabetes care, may be covered, but the plan’s conditions still apply.
Look inside the source drawer
A medicine may be eligible for coverage without your plan agreeing to pay for it.
Get the plan’s decision process
The plan records the medicines it covers in a list called its formulary.
With prior authorization, the plan needs to agree to payment before the pharmacy can supply a medicine using that coverage.
Ask the insurer which forms or records the prescriber needs to send.
Ask what your own payment would be if the request is accepted.
- Is this exact product listed for my reason for treatment?
- Does the plan need to approve payment before I collect the medicine?
- What happens if the request is refused?
Medicare has a temporary bridge
In September 2026, eligible members of qualifying Medicare drug plans can use a temporary program called the Medicare GLP-1 Bridge.
GLP-1 refers to a signal in the body with a role in appetite and blood sugar; the name also describes medicines in this program.
For certain program medicines, eligible participants pay $50 per month’s supply.
The published program dates run from July 1, 2026 to December 31, 2027.
Age, weight, health conditions, plan type and prior drug coverage all affect eligibility.
People with type 2 diabetes cannot use this bridge; their medicine coverage goes through ordinary Part D rules instead.
Look inside the source drawer
This is a temporary trial of paying for these medicines; ordinary Part D still excludes medicines used for weight loss.
The bridge payment has limits
As of September 2026, the bridge’s $50 payment is excluded from the yearly cap on your own spending under Part D.
There is no extra help for low-income participants with that payment.
You cannot use a coupon or discount program to reduce the bridge’s payment.
You need a prescription and the program’s approval to receive the bridge price.
A plan member can ask the prescriber to check the full eligibility terms rather than assume they qualify.
Ask your prescriber to submit the program’s approval request, then ask the pharmacy whether it can process your prescription through the bridge.
Look inside the source drawer
In 2026, a central service checks bridge requests and pays pharmacies; the payment does not go through your plan’s usual Part D process.
Savings cards and cash offers differ
A savings card is a discount offered by the drug maker to help with your share of the insurance bill.
As of September 2026, savings cards for branded GLP-1 medicines require workplace or private insurance and exclude Medicare and Medicaid patients.
Semaglutide is the medicine ingredient in Ozempic products used for type 2 diabetes.
Medicare patients can use some drug-maker cash prices outside insurance, including the semaglutide (Ozempic) offer described on the money page.
Ask which type of offer is being discussed and read its terms.